Jack Henry & Associates, Inc.® (Nasdaq: JKHY) announced today that it will be participating in the following upcoming conference: Greg Adelson, President & CEO, will present at Bernstein's 41st...

The National Institute of Building Sciences (NIBS) recognized outstanding contributions to the built environment during an awards luncheon at Building Innovation 2025 (BI2025), one of the premier...

Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, today announced that its Trial in Progress abstract has been...

Final data from the GAVRETO® (pralsetinib) Phase 1/2 ARROW study in RET fusion-positive NSCLC and other solid tumors Supportive data for REZLIDHIA® (olutasidenib) utilization in patients with...

Data will be shared in two oral presentations, a poster and two online abstracts Highlights include a potential novel, all-oral therapy for AML; and Phase 2 data for a novel treatment targeting...